Economic and clinical burden associated with respiratory viral infections after allogeneic hematopoietic cell transplant in the United States

BACKGROUND: Allogeneic hematopoietic cell transplant (allo‐HCT) recipients are at increased risk for respiratory viral infections (RVIs), which invoke substantial morbidity and mortality. Limited effective antiviral options and drug resistance often hamper successful RVI treatment, creating addition...

Descripción completa

Detalles Bibliográficos
Autores principales: Ison, Michael G., Marty, Francisco M., Chao, Nelson, Moon, Seung Hyun, Zhang, Zhiji, Chandak, Aastha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542538/
https://www.ncbi.nlm.nih.gov/pubmed/35598293
http://dx.doi.org/10.1111/tid.13866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542538/
https://www.ncbi.nlm.nih.gov/pubmed/35598293
http://dx.doi.org/10.1111/tid.13866

Ejemplares similares